Between 40% and 45% of COVID-19 infections could be in people who display no symptoms of the illness, according to an analysis by Scripps Research published in Annals of Internal Medicine.

A coalition of 12 surgeon groups has formed a new organization that aims to work with Congress to stop cuts to Medicare payments that could have an adverse effect on patients.

CMS has proposed a new rule that aims to enable value-based purchasing agreements across states with drug companies to bring down Medicaid drug prices.

Researchers at Cleveland Clinic have created the first risk prediction model that allows healthcare providers to find the likelihood of an individual patient testing positive for COVID—19, as well as possible outcomes from the virus.

A group of bipartisan senators have banded together to call for expanded telehealth benefits allowed during the COVID-19 pandemic to become permanent.

Walmart has expanded its digital health services by acquiring CareZone, a technology platform and mobile app that allows individuals and families to manage medicine and chronic disease.

A commonly known steroid drug has been found to greatly improve survival for COVID-19 patients. In fact, among severe patients, the steroid, Dexamethasone, reduced the number of deaths by one-third in a study conducted by the University of Oxford.

CMS Administrator Seema Verma penned an op-ed for CNN urging Americans to revisit their healthcare providers for routine care and “get back to non-COVID healthcare.”

The FDA has revoked its emergency use authorization for hydroxychloroquine as a treatment for COVID-19 hospital patients, determining that the controversial drug was “unlikely to be effective in treating COVID-19.”

It will be more than a year for the U.S. healthcare industry to return to normal, with physicians expecting the new normal to be sometime around August 2021once a vaccine for COVID-19 has been distributed.

The rule eliminates provisions of a 2016 rule from the Obama administration that attempted to protect trans patients from discrimination.

Director of the National Institute of Allergy and Infectious Disease (NIAID) and White House Advisor Anthony Fauci, MD, delved into the recent confusion about the rate of COVID-19 transmission from those who may be asymptomatic.